Regulus Therapeutics Inc logo

Regulus Therapeutics Inc Share Price (NASDAQ: RGLS)

$8.18

▲

0.04

(0.49%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 24 Jun 2025

Check the interactive Regulus Therapeutics Inc Stock chart to analyse performance

Regulus Therapeutics Inc Key Stats

Check Regulus Therapeutics Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$8.14
Open
$8.16
Market Capitalization
$565.0M
Today's Volume
$9.3M
Revenue TTM
$5.0M
EBITDA
$-51.4M
Earnings Per Share (EPS)
$-0.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-53.82%

Global Institutional Holdings in Regulus Therapeutics Inc

  • Name

    Holdings %

  • Federated Hermes Inc

    22.85%

  • NEA Management Company, LLC

    9.34%

  • Octagon Capital Advisors LP

    6.70%

  • BlackRock Inc

    6.02%

  • Vanguard Group Inc

    5.71%

  • Deep Track Capital, LP

    4.71%

Analyst Recommendation on Regulus Therapeutics Inc Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Regulus Therapeutics Inc(by analysts ranked 0 to 5 stars)

About Regulus Therapeutics Inc

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. The company has a license and collaboration agreement with Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc. to develop, manufacture, and commercialize products covered by the licensed patent rights for use in microRNA compounds. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Organization
Regulus Therapeutics Inc
Employees
34
CEO
Mr. Joseph P. Hagan M.B.A.
Industry
Health Technology

Key Management of Regulus Therapeutics Inc

NameTitle
Mr. Joseph P. Hagan M.B.A.
CEO & Director
Dr. Preston S. Klassen M.D., M.H.S.
President, Head of Research & Development and Director
Ms. Crispina Calsada CPA
Chief Financial Officer
Mr. Daniel J. Penksa
VP of Finance & Controller
Mr. Christopher Ray Aker J.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Claire Susan Padgett M.S., M.T., Ph.D.
Senior Vice President of Clinical Operations
Dr. Rekha Garg M.D., M.S.
Chief Medical Officer
Mr. Edmund Lee Ph.D.
Vice President of Translational Medicine

Important FAQs about investing in RGLS Stock from India :

What is Regulus Therapeutics Inc share price today?

Regulus Therapeutics Inc share price today is $8.18 as on at the close of the market. Regulus Therapeutics Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Regulus Therapeutics Inc share?

Regulus Therapeutics Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Regulus Therapeutics Inc stock price today i.e. is closed at $8.18, lower by 1.98% versus the 52 week high.

How to invest in Regulus Therapeutics Inc Stock (RGLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Regulus Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regulus Therapeutics Inc Shares that will get you 0.1834 shares as per Regulus Therapeutics Inc share price of $8.18 per share as on June 24, 2025 at 12:00 AM IST.

What is the minimum amount required to buy Regulus Therapeutics Inc Stock (RGLS) from India?

Indian investors can start investing in Regulus Therapeutics Inc (RGLS) shares with as little as ₹87.521 or $1 (as of August 24, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Regulus Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on August 24, 2025). Based on Regulus Therapeutics Inc share’s latest price of $8.18 as on June 24, 2025 at 12:00 AM IST, you will get 1.2225 shares of Regulus Therapeutics Inc. Learn more about fractional shares .

What are the returns that Regulus Therapeutics Inc has given to Indian investors in the last 5 years?

Regulus Therapeutics Inc stock has given 0.0% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?